Deng Q, Li W, Huang Y, Wang H, Zhou X, Guan Z
Front Oncol. 2025; 14:1531972.
PMID: 39927117
PMC: 11803635.
DOI: 10.3389/fonc.2024.1531972.
Xu L, Liu J, An Y, Zhou L, Sun H, Xu Z
BMC Cancer. 2024; 24(1):979.
PMID: 39118022
PMC: 11313097.
DOI: 10.1186/s12885-024-12747-z.
Li W, Zhang X, Yang Y, Lin J, Zhou K, Sun R
Sci Rep. 2024; 14(1):12758.
PMID: 38830909
PMC: 11148116.
DOI: 10.1038/s41598-024-63305-3.
Diaz Del Arco C, Fernandez Acenero M, Ortega Medina L
World J Gastroenterol. 2024; 30(12):1680-1705.
PMID: 38617733
PMC: 11008373.
DOI: 10.3748/wjg.v30.i12.1680.
Wu X, Shi M, Lian Y, Zhang H
Front Immunol. 2023; 14:1039084.
PMID: 37122733
PMC: 10140329.
DOI: 10.3389/fimmu.2023.1039084.
A Novel Nomogram to Predict Resectable Gastric Cancer Based on Preoperative Circulating Tumor Cell.
Xia F, Zhang Q, Ndhlovu E, Zhang M, Zou Y
Clin Transl Gastroenterol. 2023; 15(2):e00561.
PMID: 36727697
PMC: 10887436.
DOI: 10.14309/ctg.0000000000000561.
Validation of the DNA Methylation Landscape of TFF1/TFF2 in Gastric Cancer.
Qian Z, Jiang Y, Shou C, Yu J, Huang D, Xie H
Cancers (Basel). 2022; 14(22).
PMID: 36428568
PMC: 9688599.
DOI: 10.3390/cancers14225474.
Removal of Circulating Tumor Cells from Blood Samples of Cancer Patients Using Highly Magnetic Nanoparticles: A Translational Research Project.
Doswald S, Herzog A, Zeltner M, Zabel A, Pregernig A, Schlapfer M
Pharmaceutics. 2022; 14(7).
PMID: 35890293
PMC: 9315588.
DOI: 10.3390/pharmaceutics14071397.
Transcriptomic profiling of single circulating tumor cells provides insight into human metastatic gastric cancer.
Negishi R, Yamakawa H, Kobayashi T, Horikawa M, Shimoyama T, Koizumi F
Commun Biol. 2022; 5(1):20.
PMID: 35017627
PMC: 8752828.
DOI: 10.1038/s42003-021-02937-x.
Circulating tumor cells with epithelial-mesenchymal transition markers as potential biomarkers for the diagnosis of lung cancer.
Jiang S, Mao C, Feng Y, Jiang B, Tao S, Tan Q
World J Clin Cases. 2021; 9(12):2721-2730.
PMID: 33969055
PMC: 8058682.
DOI: 10.12998/wjcc.v9.i12.2721.
Cell-free DNA as a liquid biopsy for early detection of gastric cancer.
Huang Z, Zhang H, Yu B, Yu D
Oncol Lett. 2020; 21(1):3.
PMID: 33240409
PMC: 7681206.
DOI: 10.3892/ol.2020.12264.
LINC01089 is a tumor-suppressive lncRNA in gastric cancer and it regulates miR-27a-3p/TET1 axis.
Guo X, Li M
Cancer Cell Int. 2020; 20:507.
PMID: 33088215
PMC: 7568383.
DOI: 10.1186/s12935-020-01561-9.
Intraoperative blood loss as an independent prognostic factor for curative resection after neoadjuvant chemotherapy for gastric cancer: a single-center retrospective cohort study.
Hayashi M, Yoshikawa T, Yura M, Otsuki S, Yamagata Y, Morita S
Surg Today. 2020; 51(2):293-302.
PMID: 32839832
DOI: 10.1007/s00595-020-02114-3.
The role of CXCL chemokine family in the development and progression of gastric cancer.
Chen X, Chen R, Jin R, Huang Z
Int J Clin Exp Pathol. 2020; 13(3):484-492.
PMID: 32269686
PMC: 7137023.
Emerging Role of Circulating Tumor Cells in Gastric Cancer.
Huong P, Gurshaney S, Thanh Binh N, Pham A, Nguyen H, Nguyen X
Cancers (Basel). 2020; 12(3).
PMID: 32183503
PMC: 7140068.
DOI: 10.3390/cancers12030695.
Flow-regulated endothelial glycocalyx determines metastatic cancer cell activity.
Mensah S, Nersesyan A, Harding I, Lee C, Tan X, Banerjee S
FASEB J. 2020; 34(5):6166-6184.
PMID: 32167209
PMC: 7200301.
DOI: 10.1096/fj.201901920R.
Epithelial-mesenchymal transition may be involved in the immune evasion of circulating gastric tumor cells via downregulation of ULBP1.
Hu B, Tian X, Li Y, Liu Y, Yang T, Han Z
Cancer Med. 2020; 9(8):2686-2697.
PMID: 32077634
PMC: 7163085.
DOI: 10.1002/cam4.2871.
Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach.
Jung J, Nienhuser H, Schleussner N, Schmidt T
Int J Mol Sci. 2020; 21(3).
PMID: 32023907
PMC: 7038165.
DOI: 10.3390/ijms21030951.
Epithelial-mesenchymal transition of circulating tumor cells in prostate cancer is promoted by survivin.
Yang F, Ma J, Wan J, Ha W, Fang C, Lu H
J Int Med Res. 2020; 48(1):300060519892395.
PMID: 31948306
PMC: 7254165.
DOI: 10.1177/0300060519892395.
Limited Sensitivity of Circulating Tumor DNA Detection by Droplet Digital PCR in Non-Metastatic Operable Gastric Cancer Patients.
Cabel L, Decraene C, Bieche I, Pierga J, Bennamoun M, Fuks D
Cancers (Basel). 2019; 11(3).
PMID: 30901876
PMC: 6468548.
DOI: 10.3390/cancers11030396.